Fig. 3

Frequency and time cost comparisons in each month between two groups. a The percentage of discussed cases in each sequential month was compared between eMDT and cMDT groups, with subgroups of gastroesophageal and colorectal cancers compared meanwhile. b The average time cost in each sequential month was compared between eMDT and cMDT groups